How Dental M&A Is Shifting in 2026: Ten Updates for DSO Leaders

Becker’s Dental Review April 23, 2026
Read Full Article →
AI-Generated Summary

The dental M&A market is reorganizing around operational fundamentals rather than network scale. Dental Care Alliance and Affordable Care have both entered lender control, signaling the end of an acquisition-volume-driven growth model. TUSK Practice Sales reports 69% of DSOs plan to increase acquisition activity in 2026, but a high-demand, low-supply environment is forcing greater scrutiny on practice financials, staffing continuity, and post-close employment terms — with more DSOs now requiring a minimum five-year post-close commitment. Seventy-eight percent of DSOs anticipate recapitalizations within 12 to 36 months. Several groups are shifting toward de novos as a cost-effective expansion alternative, while multiple states have introduced legislation limiting corporate ownership of dental practices and its influence on clinical decision-making. PE interest continues, with specific focus on smaller DSOs and oral surgery platforms.

Why It Matters

DSO executives and their PE sponsors need a clear read on current market conditions. The shift from growth-at-any-cost to operational density, financial sustainability, and clinical alignment isn’t just a strategy preference — it’s being enforced by lenders, regulators, and a constrained deal pipeline simultaneously.

dental M&A DSO acquisitions de novo dental recapitalization dental private equity lender control clinical alignment

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Similar Posts